Search - tctmd.com

Displaying 221 - 240 of 420

Sort: Relevancy | Date

Presentation TCT 2016

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Presenter: Fernando Alfonso, Stephan Windecker

October 30, 2016

Presentation TCT 2016

Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis

Presenter: Fernando Alfonso, Stephan Windecker, Ehrin J. Armstrong

October 30, 2016

Presentation TCT 2016

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Presenter: Fernando Alfonso, Stephan Windecker, Giulio G. Stefanini

October 30, 2016

Presentation TCT 2016

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Presenter: Fernando Alfonso, Stephan Windecker, Robert-Jan van Geuns

October 30, 2016

Presentation TCT 2016

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

Presenter: Fernando Alfonso, Stephan Windecker, Giulio Guagliumi

October 30, 2016

Presentation TCT 2016

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Presenter: Fernando Alfonso, Stephan Windecker, Stephen WL Lee

October 30, 2016

Presentation TCT 2016

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

Presenter: Fernando Alfonso, Stephan Windecker, Gary S. Mintz

October 30, 2016

Presentation TCT 2016

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Presenter: Fernando Alfonso, Stephan Windecker, Akiko Maehara

October 30, 2016

Presentation TCT 2016

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Presenter: Fernando Alfonso, Stephan Windecker, Yasunori Ueda

October 30, 2016

Presentation TCT 2016

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Presenter: Fernando Alfonso, Stephan Windecker, Elazer R. Edelman

October 30, 2016

Presentation TCT 2016

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Presenter: Fernando Alfonso, Stephan Windecker, Juan F. Granada

October 30, 2016

Presentation TCT 2016

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Presenter: Fernando Alfonso, Stephan Windecker, Aloke V. Finn

October 30, 2016

Presentation TCT 2016

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

Presenter: Fernando Alfonso, Stephan Windecker, Mahesh V Madhavan

October 30, 2016

Presentation TCT 2016

Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History!

Presenter: Manel Sabate, Robert-Jan van Geuns, Sunil V. Rao

October 30, 2016

Presentation TCT 2016

Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role!

Presenter: Manel Sabate, Robert-Jan van Geuns, Eric R. Bates

October 30, 2016

Presentation TCT 2016

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? Yes There Are Important Distinctions Relevant to Our Patients!

Presenter: Manel Sabate, Robert-Jan van Geuns

October 30, 2016

Presentation TCT 2016

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? No for All Practical Purposes the Outcomes Are Similar!

Presenter: Manel Sabate, Robert-Jan van Geuns, Julinda Mehilli

October 30, 2016

Presentation TCT 2016

The Last Word on DES in Diabetics: Two-Year TUXEDO Outcomes

Presenter: Dean J. Kereiakes, Pieter C. Smits, Upendra Kaul

October 30, 2016

Presentation TCT 2016

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

Presenter: Dean J. Kereiakes, Pieter C. Smits, Patrick W. Serruys

October 30, 2016

Presentation TCT 2016

Comparative DES Outcomes: What Have We Learned From the SCAAR Registry? Update on Recent New Generation DES

Presenter: Dean J. Kereiakes, Pieter C. Smits, Stefan K. James

October 30, 2016

Advertisement

Prognosis and Treatment Options for DES Restenosis and Re-restenosis

Case Presentation: A Surprise in the Evaluation and Management of Stent Thrombosis

How to Evaluate and Treat the Patient With Metallic Stent Thrombosis: The Usual Suspects and Beyond

Are All Stent Thromboses Prognostically Created Equal? Impact of Original Clinical Presentation, Stent Location and Thrombosis Timing

Is the OCT-derived Healing Score A Meaningful Metric to Evaluate Stent Safety?

OCT-assessed Rate of Early Strut Coverage: Differences Between DES and Its Implications

Is Acute or Late Acquired Malapposition By IVUS or OCT A Risk Factor for Stent Thrombosis?

New Insights Into the Mechanisms and Patterns of in-stent Restenosis in BMS and DES Evaluated By IVUS and OCT (With Case Examples)

Neoatherosclerosis as A Cause of Very Late DES Failure: Insights From Multimodality Imaging Studies

Can Improvements in Metallurgy and Stent Design Improve Early and Late Outcomes With DES?

Mechanisms of Late and Very Late Restenosis: Is Improved Technology the Answer?

Pathologic Insights Into Vascular Healing and the Causes of Stent Thrombosis and Restenosis: Are We Making Progress as Stents Evolve?

Very Late Failures After Metallic DES: Frequency and Clinical Predictors

Great Debate 2: Implications from NORSTENT: BMS Are Yesterday's History!

Great Debate 2: Implications from NORSTENT: BMS will Continue to Play an Important Role!

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? Yes There Are Important Distinctions Relevant to Our Patients!

Great Debate 1: Are There Any MAJOR Differences in Mechanical Performance or Outcomes Between the Most Widely Used Contemporary Metallic DES? No for All Practical Purposes the Outcomes Are Similar!

The Last Word on DES in Diabetics: Two-Year TUXEDO Outcomes

Have Contemporary DES Narrowed the Gap With CABG in Multivessel Disease? From BEST to SYNTAX II and Beyond

Comparative DES Outcomes: What Have We Learned From the SCAAR Registry? Update on Recent New Generation DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content